The Cancer Letter Archives
The Cancer Letter was founded in 1973, two years after Congress passed the National Cancer Act of 1971. These archives represent the first 40 years of The Cancer Letter, which is published weekly.
TCL
Vol.
35
No.
27
July 10, 2009
TCL
Vol.
35
No.
30
July 31, 2009
CCL
Vol.
32
No.
7
July 31, 2009
- Phase III Trial Of PARP Inhibitor BSI-201 Opens For Triple-Negative Breast Cancer
- Studies Shed Light On Racial Disparities Between Blacks, Whites With Breast Cancer
- Shorter, Simpler Consent Form Proposed For Phase I Trials
- How Much Is Life Worth? The $440 Billion Question
- Sunitinib Prolongs Survival In Poor Prognosis, Study Finds
- Breast MRI Recipients More Likely To Choose Mastectomy
- Opioid Pain Reliever Approved With Risk Reduction Plan
- NCI Cooperative Group Clinical Trials Approved
CCL
Vol.
32
No.
8
August 28, 2009
- More Cost-Effective To Use Cetuximab In Patients With Wild-Type KRAS Gene
- Older Women More Likely To Receive Lower Chemotherapy Doses, Study Finds
- ASTRO Issues Statement On APBI For Breast Cancer
- Denosumab Demonstrates Superiority Over Zometa For Bone Metastases
- Lymphedema Education Helps Reduce Symptoms, Study Finds
- Exercise May Help Combat Leukemia Patients’ Fatigue
- Cranial Radiation Eliminated With Personalized Chemo
- Young Early-Stage Patients Can Preserve Fertility
- Limb-Sparing Surgery May Not Offer Better Quality of Life
- AIDS Patients Face Higher Risk Of HPV-Related Cancers As Immunosuppression Grows
- Budesonide Not Beneficial For Diarrhea In Melanoma
- NCI Cooperative Group Clinical Trials Approved
